Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Elimination of Mast Cells via Siglec-6-Targeted Nanodelivery of Drug Payload.

The Journal of allergy and clinical immunology·2026
Same author

Optimizing Pichia Pastoris Cell-Free Protein Synthesis to Improve Economics.

Biotechnology and bioengineering·2026
Same author

Design-driven optimization of low-cost reagent formulations for reproducible and high-yielding cell-free gene expression.

Nature communications·2026
Same author

The Impact of Methanol Concentration on Recombinant Protein Glycosylation in Pichia pastoris SuperMan5.

Microbial biotechnology·2025
Same author

Coexistence and collaboration: engineering encapsulation for whole-cell biosensors.

Trends in biotechnology·2025
Same author

A Scalable Cell-Free Manufacturing Platform for Two-Step Bioproduction of Immunogenic Conjugate Vaccines.

ACS synthetic biology·2025

Related Experiment Video

Updated: Jul 17, 2026

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris
09:46

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris

Published on: February 25, 2010

46.8K

Methods for Expression of Recombinant Proteins Using a Pichia pastoris Cell-Free System.

Rochelle Aw1,2, Alex J Spice1,2, Karen M Polizzi1,2

  • 1Imperial College Centre for Synthetic Biology, Imperial College London, London, United Kingdom.

Current Protocols in Protein Science
|October 27, 2020
PubMed
Summary

This study presents Pichia pastoris cell-free protein synthesis methods, enabling rapid in vitro protein production. These protocols facilitate eukaryotic protein engineering and biomanufacturing applications.

Keywords:
Komagataella phaffiiPichia pastoriscell-free protein synthesiseukaryotic cell-free expression systemin vitro transcription-translationrapid prototypingsynthetic biology

More Related Videos

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
07:09

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Published on: July 31, 2012

21.7K
Methanol Independent Expression by Pichia Pastoris Employing De-repression Technologies
05:30

Methanol Independent Expression by Pichia Pastoris Employing De-repression Technologies

Published on: January 23, 2019

14.2K

Related Experiment Videos

Last Updated: Jul 17, 2026

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris
09:46

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris

Published on: February 25, 2010

46.8K
A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
07:09

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Published on: July 31, 2012

21.7K
Methanol Independent Expression by Pichia Pastoris Employing De-repression Technologies
05:30

Methanol Independent Expression by Pichia Pastoris Employing De-repression Technologies

Published on: January 23, 2019

14.2K

Area of Science:

  • Synthetic Biology
  • Biotechnology
  • Molecular Biology

Background:

  • Cell-free protein synthesis (CFPS) offers rapid, on-demand in vitro protein production by leveraging cellular machinery outside of living cells.
  • Eukaryotic CFPS platforms are often overlooked despite advantages over prokaryotic systems, such as complex protein folding and post-translational modifications.
  • Pichia pastoris (Komagataella phaffii) is a robust eukaryotic host suitable for high-density growth and genetic manipulation, making it ideal for CFPS extract generation.

Purpose of the Study:

  • To describe and standardize methodologies for Pichia pastoris-based cell-free protein synthesis.
  • To provide accessible protocols for preparing P. pastoris cell lysates and conducting coupled and linked transcription-translation reactions.
  • To encourage broader adoption of eukaryotic P. pastoris CFPS for diverse biological engineering applications.

Main Methods:

  • Preparation of Pichia pastoris cell lysate for cell-free reactions.
  • Coupled in vitro transcription and translation (IVTT) protocols.
  • Linked IVTT protocols, including mRNA preparation.
  • Quantification of protein production (e.g., luciferase, HSA).

Main Results:

  • Established robust protocols for P. pastoris cell-free extract preparation.
  • Demonstrated successful coupled and linked transcription-translation reactions using P. pastoris extracts.
  • Provided methods for quantifying protein yields, enabling reaction optimization.

Conclusions:

  • Pichia pastoris serves as an effective eukaryotic host for cell-free protein synthesis.
  • Standardized protocols facilitate the use of P. pastoris CFPS for research and industrial applications.
  • This work promotes the utilization of eukaryotic CFPS for advanced protein engineering and biomanufacturing.